R3 Stem Cell Now Offering Umbilical Cord Tissue Regenerative Therapy

Wednesday, July 25, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

R3 Stem Cell is now offering umbilical cord tissue regenerative procedures nationwide at over thirty Centers. The first rate biologics offer excellent outcomes, are very safe, and are performed by highly qualified providers.

PHOENIX, July 25, 2018 /PRNewswire-PRWeb/ -- R3 Stem Cell is now offering umbilical cord tissue regenerative procedures

nationwide at over thirty Centers. The first rate stem cell therapies offer excellent outcomes, are very safe, and are performed by highly qualified providers.

Over the past few years, R3 Stem Cell has been at the forefront of regenerative therapies for all types of conditions, whether it's localized arthritis or a systemic condition. All of the procedures are performed as an outpatient, with the biologics being FDA regulated.

Umbilical cord tissue offers an impressive array of regenerative cells. These include growth factors, cytokines, stem cells, exosomes, secretomes and micro RNA. The tissue comes from consenting donors after a scheduled c-section, where the babies are fine and no embryonic stem cells are used. It's both safe and highly effective for patients with arthritis, autoimmune conditions, neurodegenerative and organ failure.

Complex conditions are treated at the R3 Concierge locations in Las Vegas and NYC by Board Certified providers. Conditions such as post-stroke, trigeminal neuralgia, COPD and others receive the umbilical cord stem cell therapies there. Each patient receives a dedicated Concierge Representative to set up a complimentary phone consultation, and assists with obtaining medical records and all travel logistics.

For those interested in receiving first rate umbilical cord stem cell therapies, simply call (844) GET-STEM today to set up a free consultation.

 

SOURCE R3 Stem Cell



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store